These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31115494)

  • 1. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
    Pu L; Su L; Kang X
    Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.
    Zhou C; Shen G; Yang F; Duan J; Wu Z; Yang M; Liu Y; Du X; Zhang X; Xiao S
    J Cell Mol Med; 2020 Jun; 24(11):6438-6447. PubMed ID: 32307891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.
    Liu F; Tang L; Liu H; Chen Y; Xiao T; Gu W; Yang H; Wang H; Chen P
    Cell Death Dis; 2024 Apr; 15(4):279. PubMed ID: 38637504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of serpin peptidase inhibitor clade C member 1 inhibits the growth of nasopharyngeal carcinoma cells.
    Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
    Mol Med Rep; 2019 May; 19(5):3658-3666. PubMed ID: 30896875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
    Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma.
    Xi H; He Z; Lv C
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy related 4B, upregulated by HIF-1α, attenuates the sensitivity to cisplatin in nasopharyngeal carcinoma cells.
    Huang J; Li HB; Yu S; Yuan F; Lou ZP
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4793-4802. PubMed ID: 32432742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM24 siRNA induced cell apoptosis and reduced cell viability in human nasopharyngeal carcinoma cells.
    Wang P; Shen N; Liu D; Ning X; Wu D; Huang X
    Mol Med Rep; 2018 Jul; 18(1):369-376. PubMed ID: 29749443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin α5 mediates intrinsic cisplatin resistance in three-dimensional nasopharyngeal carcinoma spheroids via the inhibition of phosphorylated ERK /caspase-3 induced apoptosis.
    Ngaokrajang U; Janvilisri T; Sae-Ueng U; Prungsak A; Kiatwuthinon P
    Exp Cell Res; 2021 Sep; 406(2):112765. PubMed ID: 34358523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
    Yin P; Song G; Jiang Z
    Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells.
    Bian LH; Duan JL; Zhou C; Shen GW; Wang XY; Yang Y; Zhang XL; Xiao SJ
    Mol Med Rep; 2020 Jul; 22(1):51-56. PubMed ID: 32377721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 14. Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.
    Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
    Mol Med Rep; 2019 Jul; 20(1):409-416. PubMed ID: 31180550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of glucose-regulated protein 78 enhances the cytotoxic effects of curcumin on human nasopharyngeal carcinoma cells.
    Yu X; Shi L; Yan L; Wang H; Wen Y; Zhang X
    Int J Mol Med; 2018 Nov; 42(5):2943-2951. PubMed ID: 30226563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
    BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
    Wang Y; Cheng N; Luo J
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.
    Sinnung S; Janvilisri T; Kiatwuthinon P
    Mol Cell Biochem; 2021 Apr; 476(4):1663-1672. PubMed ID: 33423190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.
    Li D; Ye L; Lei Y; Wan J; Chen H
    BMB Rep; 2019 Mar; 52(3):208-213. PubMed ID: 30638177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1.
    Dong H; Huang C; Huang J
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.